专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US06210686B1 Dietary supplement and method for lowering risk of heart disease 失效
标题翻译：膳食补充剂和降低心脏病风险的方法
公开(公告)号：US06210686B1
公开(公告)日：2001-04-03
申请号：US09215353
申请日：1998-12-18
申请人： Stacey J. Bell , R. Armour Forse , Bruce R. Bistrian
发明人： Stacey J. Bell , R. Armour Forse , Bruce R. Bistrian
IPC分类号： A61K31355
CPC分类号： A61K31/435 , A23L33/21 , A23L33/40 , A23V2002/00 , A61K31/355 , A61K31/4415 , A61K31/495 , Y10S514/824 , Y10S514/904 , Y10S514/948 , A61K2300/00 , A23V2250/218 , A23V2250/7052 , A23V2250/706 , A23V2250/712 , A23V2250/5034 , A23V2250/5058
摘要： Yeast-derived fiber has been demonstrated, as described herein, to effectively improve the serum lipid profile in humans, when provided as a dietary supplement, without some of the disadvantages known to accompany dietary supplementation with oat fiber or psyllium fiber. Described herein are dietary supplements comprising yeast fiber, e.g., &bgr;-glucan or glucomannan, and further comprising folic acid or a salt thereof, vitamin B6, vitamin B12, and vitamin E. The dietary supplements of the invention can further comprise fats, carbohydrates and proteins, for example, and other ingredients added to formulate a food product. Such food products can be in the form, for example, of solid or semi-solid foods, such as food bars, pudding, or spreads. By including folate and vitamin B6, the dietary supplement provides a second benefit of suppressing the level of homocysteine in the blood. A third benefit is provided by the anti-oxidant properties of vitamin E, particularly the effect of preserving low density lipoproteins from oxidation. Further embodiments of the invention are methods for improving the serum lipid profile in a human, methods for lowering risk of heart disease, and methods for improving cardiovascular health in a human, comprising administering to the human a dietary supplement of the invention.
摘要翻译：如本文所述，已经证明了酵母衍生的纤维，当作为膳食补充剂提供时，有效地改善了人类的血清脂质谱，而没有已知的与燕麦纤维或欧车前纤维的膳食补充剂相关的一些缺点。本文描述的是包含酵母纤维例如β-葡聚糖或葡甘露聚糖并且还包含叶酸或其盐，维生素B6，维生素B12和维生素E的膳食补充剂。本发明的膳食补充剂还可以包含脂肪，碳水化合物和蛋白质，以及其它添加成分配食品的成分。这样的食品可以是例如固体或半固体食物，例如食物棒，布丁或散布物的形式。通过包括叶酸和维生素B6，膳食补充剂提供了抑制血液中同型半胱氨酸水平的第二个好处。维生素E的抗氧化性质，特别是保护低密度脂蛋白氧化的作用提供了第三个益处。本发明的其它实施方案是用于改善人类血清脂质分布的方法，用于降低心脏病风险的方法，以及改善人类心血管健康的方法，包括向人类施用本发明的膳食补充剂。

2. 发明授权

US5968896A Nutritional supplement for preoperative feeding 失效
标题翻译：营养补充剂用于术前喂养
公开(公告)号：US5968896A
公开(公告)日：1999-10-19
申请号：US8156
申请日：1998-01-16
申请人： Stacey J. Bell , R. Armour Forse , Bruce R. Bistrian
发明人： Stacey J. Bell , R. Armour Forse , Bruce R. Bistrian
IPC分类号： A23L1/29 , A23L1/30 , A61K38/01 , A61K38/00 , A61K31/595 , A61K31/70 , A61K31/715
CPC分类号： A61K38/018 , A23L33/115 , A23L33/40 , A23V2002/00
摘要： A nutritional supplement is described comprising approximately from about 10 to about 75 grams carbohydrate; approximately from about 5 to about 50 grams protein; approximately from about 3 to about 30 grams fat; and therapeutic amount of antioxidant, for use in weight maintenance in individuals who will undergo major surgery to prevent or reduce postoperative complications.
摘要翻译：描述了营养补充剂，其包含约10至约75克碳水化合物; 约5至约50克蛋白质; 约3至约30克脂肪; 和治疗量的抗氧化剂，用于将进行大手术以防止或减少术后并发症的个体的体重维持。

3. 发明授权

US5902797A Nutritional supplement for use in the treatment of attention deficit 失效
标题翻译：营养补充剂用于治疗注意力缺陷
公开(公告)号：US5902797A
公开(公告)日：1999-05-11
申请号：US966829
申请日：1997-11-10
申请人： Stacey J. Bell , R. Armour Forse , Bruce R. Bistrian , Robert C. Jones
发明人： Stacey J. Bell , R. Armour Forse , Bruce R. Bistrian , Robert C. Jones
IPC分类号： A23L1/29 , A23L1/30 , A23L1/305 , A61K47/00
CPC分类号： A23L33/17 , A23L33/115 , A23L33/40 , A23V2002/00 , Y10S426/801 , Y10S426/808 , Y10S514/922 , Y10S514/948 , Y10S514/964
摘要： A nutritional supplement comprising approximately from about 5 to about 25 grams carbohydrate; approximately from about 1 to about 25 grams protein; and approximately from about 1 to about 10 grams fat, for use in treating low appetite that may result in weight loss, is described.
摘要翻译：包含约5至约25克碳水化合物的营养补充剂; 约1至约25克蛋白质; 和约1至约10克脂肪，用于治疗可能导致体重减轻的低食欲。

4. 发明授权

US5866555A Diabetic supplement bar 失效
公开(公告)号：US5866555A
公开(公告)日：1999-02-02
申请号：US815595
申请日：1997-03-12
申请人： Stacey J. Bell , Robert C. Jones , Bruce R. Bistrian , R. Armour Forse
发明人： Stacey J. Bell , Robert C. Jones , Bruce R. Bistrian , R. Armour Forse
IPC分类号： A23L1/29 , A23L1/30 , A23L1/305 , A61K31/715
CPC分类号： A23L33/17 , A23L33/00 , A23L33/115 , A23L33/40 , A23V2002/00
摘要： A novel diabetic supplement bar which includes about 10-60% by weight simple carbohydrate, about 1-25% by weight protein, about 2-40% by weight lipid and about 1-60%, preferably about 5-35% by weight complex carbohydrate. This formulation is particularly useful for the treatment or prevention of nighttime hypoglycemia in diabetic patients who require insulin injections.

5. 发明授权

US6156738A Diabetic supplement bar 失效
标题翻译：糖尿病补充酒吧
公开(公告)号：US6156738A
公开(公告)日：2000-12-05
申请号：US241004
申请日：1999-02-01
申请人： Stacey J. Bell , Robert C. Jones , Bruce R. Bistrian , R. Armour Forse
发明人： Stacey J. Bell , Robert C. Jones , Bruce R. Bistrian , R. Armour Forse
IPC分类号： A23L1/09 , A23L1/10 , A23L1/16 , A23L1/29 , A23L1/30 , A23L1/305 , A61K31/00 , A61K31/225 , A61K31/70 , A61K31/7004 , A61K31/7016 , A61K31/715 , A61K36/18 , A61K38/00 , A61P3/00 , A61P3/10
CPC分类号： A23L33/17 , A23L33/10 , A23L33/115 , A23L33/40 , A23V2002/00 , Y10S514/866
摘要： A novel diabetic supplement bar which includes about 10-60% by weight simple carbohydrate, about 1-25% by weight protein, about 2-40% by weight lipid and about 1-60%, preferably about 5-35% by weight complex carbohydrate. This formulation is particularly useful for the treatment or prevention of nighttime hypoglycemia in diabetic patients who require insulin injections.
摘要翻译：一种新型糖尿病补充酒吧，其包含约10-60重量％的简单碳水化合物，约1-25重量％的蛋白质，约2-40重量％的脂质和约1-60重量％，优选约5-35重量％的复合物糖类。该制剂对于需要胰岛素注射的糖尿病患者的夜间低血糖的治疗或预防特别有用。

6. 发明授权

US5998363A Enteral formulation: low in fat and containing protein hydrolysates 失效
标题翻译：肠内配方：脂肪含量低，含有蛋白质水解物
公开(公告)号：US5998363A
公开(公告)日：1999-12-07
申请号：US168796
申请日：1998-10-08
申请人： R. Armour Forse , Stacey J. Bell , Peter Burke
发明人： R. Armour Forse , Stacey J. Bell , Peter Burke
IPC分类号： A23L1/29 , A23L1/305 , A61K38/01 , A61K38/00 , A61K31/22 , A61K31/70 , A61K31/715
CPC分类号： A61K38/012 , A23L33/18 , A23L33/40 , A61K38/018 , A23V2002/00
摘要： An improved enteral formulation that is low in fat and contains protein hydrolysates has been developed. The osmolality of the formulation is controlled to be below 500 mOs/kg H.sub.2 O, preferably about 300 mOs/kg H.sub.2 O. In a preferred embodiment, the formulation contains corn starch to control blood glucose levels. This formulation is particularly useful for treatment of critically ill patients and in minimizing a risk of pulmonary aspiration and/or gastrointestinal dysfunction in such patients.
摘要翻译：已经开发了一种脂肪低和含有蛋白质水解产物的改良肠内制剂。将制剂的重量克分子渗透浓度控制在低于500mOs / kg H 2 O，优选约300mOs / kg H 2 O。在优选的实施方案中，制剂含有玉米淀粉以控制血糖水平。该制剂对于危重病人的治疗和使患者肺吸入和/或胃肠功能障碍的风险最小化特别有用。

7. 发明授权

US5674853A Enternal formulations for treatment of inflammation and infection 失效
标题翻译：用于治疗炎症和感染的内在制剂
公开(公告)号：US5674853A
公开(公告)日：1997-10-07
申请号：US399542
申请日：1995-03-07
申请人： R. Armour Forse , Sambasiva Chavali
发明人： R. Armour Forse , Sambasiva Chavali
IPC分类号： A23L1/30 , A01N25/00 , A01N43/04 , A01N43/30 , A01N65/00 , A23L1/03 , A23L1/302 , A23L1/304 , A61K31/23 , A61K31/34 , A61K31/36 , A61K31/38 , A61K31/70 , A61K33/00 , A61K35/60 , A61K36/18 , A61K36/185 , A61K36/28 , A61K36/30 , A61K36/31 , A61P3/00 , A61P29/00 , A61P43/00 , C07D493/04
CPC分类号： A61K36/30 , A61K36/185 , A61K36/31 , Y10S424/13 , Y10S426/804 , Y10S426/81 , Y10S514/825 , Y10S514/886 , Y10S514/887 , Y10S514/904 , Y10S514/905
摘要： The present invention features saponin containing enteral formulations for treatment of infection and inflammation. These saponin containing formulations are particularly useful in conjunction with oils rich in .omega.3 polyunsaturated fatty acids such as fish oils and flax oil but also show benefits with .omega.6 rich oils such as borage oil, black currant seed oil, canola oil and rapeseed oil. These formulations may also contain a lignan from the sesamin family.
摘要翻译：本发明涉及含有用于治疗感染和炎症的含有肠溶制剂的皂苷。含有这些含皂苷的制剂特别适用于富含ω-3多不饱和脂肪酸的油类，例如鱼油和亚麻油，但也显示出富含欧6的富油，如琉璃苣油，黑醋栗籽油，菜籽油和菜籽油的益处。这些制剂还可以含有来自芝麻素家族的木脂素。

8. 发明授权

US5762935A Anti-inflammatory and infection protective effects of sesamin-based lignans 失效
标题翻译：基于芝麻素的木脂素的抗炎和感染保护作用
公开(公告)号：US5762935A
公开(公告)日：1998-06-09
申请号：US429014
申请日：1995-04-26
申请人： R. Armour Forse , Sambasiva Chavali
发明人： R. Armour Forse , Sambasiva Chavali
IPC分类号： A23L1/30 , A23L1/03 , A23L1/302 , A23L1/304 , A61K31/34 , A61K31/36 , A61K31/38 , A61K36/18 , A61K36/185 , A61K36/30 , A61K36/31 , A61P3/00 , A61P29/00 , C07D493/04 , A61K35/78
CPC分类号： A61K36/185 , A61K36/30 , A61K36/31 , Y10S514/885
摘要： The uses of lignans of the sesamin family to treat infection and inflammation is disclosed. These lignans may be delivered enterally or parenterally and either in the form of sesame oil or in purified form. A total parenteral nutrition solution or dietary supplement are the preferred forms of administration.
摘要翻译：公开了芝麻素家族的木脂素用于治疗感染和炎症的用途。这些木脂素可以肠或肠胃外递送，或以芝麻油或纯化形式递送。全肠外营养溶液或膳食补充剂是优选的给药形式。

9. 发明授权

US5403590A Method of pulsatile drug infusion 失效
标题翻译：搏动药物输注方法
公开(公告)号：US5403590A
公开(公告)日：1995-04-04
申请号：US994198
申请日：1992-12-21
申请人： R. Armour Forse
发明人： R. Armour Forse
IPC分类号： A61K9/00 , A61K31/135 , A61K9/08
CPC分类号： A61K9/0002 , A61K31/135
摘要： A method of pulsatile infusion of a drug or other therapeutic agent is described. The pulsatile infusion method minimizes tachyphylaxis, while enabling the target cell, tissue, or organ to benefit from the administered drug or other therapeutic agent. The drug or other therapeutic agent, an agonist or antagonist for a molecule of the receptor system, is administered in a succession of at least two pulses. The pulses have a selected amplitude and duration so that the binding affinity of the receptor system molecule is decreased by a predetermined amount in response to each pulse. This predetermined amount is less than the difference between the maximum binding affinity of the receptor system molecule, when it is not exposed to either the agonist or antagonist, and its minimum binding affinity for the agonist or antagonist, when it is continuously exposed to the agonist or antagonist. The pulses are spaced apart by a selected interpulse period wherein the binding affinity of the receptor system molecule increases to the maximum value.
摘要翻译：描述了药物或其它治疗剂的脉动输注方法。脉冲输注方法可以最大限度地减少病痛，同时使靶细胞，组织或器官能够从施用的药物或其它治疗剂中获益。药物或其他治疗剂，受体系统分子的激动剂或拮抗剂以连续的至少两个脉冲施用。脉冲具有选定的幅度和持续时间，使得受体系统分子的结合亲和力响应于每个脉冲减少预定量。当预定量不受暴露于激动剂或拮抗剂时，受体系分子的最大结合亲和力及其对激动剂或拮抗剂的最小结合亲和力当其连续暴露于激动剂或拮抗剂。脉冲间隔开选定的脉冲间隔，其中受体系统分子的结合亲和力增加到最大值。

10. 发明授权

US5397778A Enteral formulations for treatment of inflammation and infection 失效
标题翻译：用于治疗炎症和感染的肠内制剂
公开(公告)号：US5397778A
公开(公告)日：1995-03-14
申请号：US228599
申请日：1994-04-15
申请人： R. Armour Forse , Sambasiva Chavali
发明人： R. Armour Forse , Sambasiva Chavali
IPC分类号： A23L1/30 , A01N25/00 , A01N43/04 , A01N43/30 , A01N65/00 , A23L1/03 , A23L1/302 , A23L1/304 , A61K31/23 , A61K31/34 , A61K31/36 , A61K31/38 , A61K31/70 , A61K33/00 , A61K35/60 , A61K36/18 , A61K36/185 , A61K36/28 , A61K36/30 , A61K36/31 , A61P3/00 , A61P29/00 , A61P43/00 , C07D493/04
CPC分类号： A61K36/30 , A61K36/185 , A61K36/31 , Y10S424/13 , Y10S426/804 , Y10S426/81 , Y10S514/825 , Y10S514/886 , Y10S514/887 , Y10S514/904 , Y10S514/905
摘要： The present invention features saponin containing enteral formulations for treatment of infection and inflammation. These saponin containing formulations are particularly useful in conjunction with oils rich in .omega.3 polyunsaturated fatty acids such as fish oils and flax oil but also show benefits with .omega.6 rich oils such as borage oil, black currant seed oil, canola oil and rapeseed oil. These formulations may also contain a lignan from the sesamin family.
摘要翻译：本发明涉及含有用于治疗感染和炎症的含有肠溶制剂的皂苷。含有这些含皂苷的制剂特别适用于富含ω-3多不饱和脂肪酸的油类，例如鱼油和亚麻油，但也显示出富含欧6的富油，如琉璃苣油，黑醋栗籽油，菜籽油和菜籽油的益处。这些制剂还可以含有来自芝麻素家族的木脂素。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式